Literature DB >> 1612026

Transforming growth factor-beta blocks protein kinase-A-mediated iodide transport and protein kinase-C-mediated DNA synthesis in FRTL-5 rat thyroid cells.

X P Pang1, M Park, J M Hershman.   

Abstract

Recent studies have shown that transforming growth factor-beta (TGF beta) alters DNA synthesis and iodide metabolism in human, porcine, and rat thyroid cells. In the present work we studied the mechanism of TGF beta action in FRTL-5 rat thyroid cells. The cells were treated with TGF beta in the presence of TSH, growth factors, and cellular modulators for various periods of time; then, [3H]thymidine incorporation and DNA content were measured as indicators of DNA synthesis, and [125I]iodide uptake was measured to assess cell function. TGF beta (10 ng/ml) inhibited TSH-induced DNA synthesis and iodide uptake. TGF beta also inhibited DNA synthesis induced by insulin-like growth factor-I, fibroblast growth factor, and endothelial cell growth factor. The protein kinase-A (PKA) activator 8-bromo-cAMP increased both iodide uptake and DNA synthesis; TGF beta inhibited 8-bromo-cAMP-induced [125I]iodide uptake, but not [3H]thymidine incorporation. The protein kinase-C (PKC) activator phorbol 12-myristate 13-acetate increased [3H]thymidine incorporation, and TGF beta inhibited this action of phorbol 12-myristate 13-acetate. The results show that activation of PKA or PKC increases DNA synthesis. TGF beta inhibited PKC-mediated, but not PKA-mediated, DNA synthesis in these cells. The results also show that TGF beta selectively inhibits PKA-mediated iodide uptake, but not PKA-mediated DNA synthesis. These findings suggest that TGF beta is a strong inhibitor of the proliferation and function of thyroid cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1612026     DOI: 10.1210/endo.131.1.1612026

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  From differentiation to proliferation: the secretory amyloid precursor protein as a local mediator of growth in thyroid epithelial cells.

Authors:  C U Pietrzik; J Hoffmann; K Stöber; C Y Chen; C Bauer; D A Otero; J M Roch; V Herzog
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

Review 2.  Action of tumor necrosis factor-alpha on thyroid cells.

Authors:  J M Hershman; X P Pang
Journal:  Trans Am Clin Climatol Assoc       Date:  1994

Review 3.  The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.

Authors:  Takahiko Kogai; Gregory A Brent
Journal:  Pharmacol Ther       Date:  2012-06-29       Impact factor: 12.310

4.  Transforming growth factor-beta 1 is more expressed in thyroid follicular adenoma than in normal tissue.

Authors:  P Morosini; A Taccaliti; C Di Loreto; G Arnaldi; E Faloia; G Giacchetti; F Mantero
Journal:  J Endocrinol Invest       Date:  1994-05       Impact factor: 4.256

5.  EGF and TGF-β1 Effects on Thyroid Function.

Authors:  Gabriella Mincione; Maria Carmela Di Marcantonio; Chiara Tarantelli; Sonia D'Inzeo; Arianna Nicolussi; Francesco Nardi; Caterina Francesca Donini; Anna Coppa
Journal:  J Thyroid Res       Date:  2011-06-13

Review 6.  Fluoride Exposure Induces Inhibition of Sodium/Iodide Symporter (NIS) Contributing to Impaired Iodine Absorption and Iodine Deficiency: Molecular Mechanisms of Inhibition and Implications for Public Health.

Authors:  Declan Timothy Waugh
Journal:  Int J Environ Res Public Health       Date:  2019-03-26       Impact factor: 3.390

Review 7.  Unraveling the Complex Interplay Between Transcription Factors and Signaling Molecules in Thyroid Differentiation and Function, From Embryos to Adults.

Authors:  Arístides López-Márquez; Carlos Carrasco-López; Celia Fernández-Méndez; Pilar Santisteban
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-20       Impact factor: 5.555

8.  Overexpression of USF increases TGF-beta1 protein levels, but G1 phase arrest was not induced in FRTL-5 cells.

Authors:  Keun-Sook Kim; Hye Seung Jung; Yun Jae Chung; Tae Sik Jung; Hye Won Jang; Myung-Shik Lee; Kwang-Won Kim; Jae Hoon Chung
Journal:  J Korean Med Sci       Date:  2008-10       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.